New: The Itinerary Builder
Be one of the first ONS members to try the Itinerary Builder, a new resource that helps you generate a customized schedule online. You can browse conference sessions by description, speaker, title, and time, and then add your choices to a personalized schedule. For more information and to try it, click here now! |
8th Annual Institutes of Learning
November 9-11
Chicago, IL
Bring IOL 2007 Home!
Sessions from IOL 2007 are available for purchase on MP3 audio CD-ROM or as downloadable media. Sessions feature speakers' PowerPoint presentations synchronized with the session audio. Place your order online now.
Head to the Windy City, Where ONS Educational Offerings Will Blow You Away!
The ONS 8th Annual Institutes of Learning is a one-of-a-kind educational
experience that provides you with practical, hands-on knowledge that you
can take home and use in your practice—the kind of knowledge you
can’t get anywhere else.
We Listened to You to Make IOL Even Better
We have heard your call. Based on your feedback, the conference format
now features half-day, interactive mini institutes so that you can pick
the two that interest you most.
The mini institutes, as well as 90-minute
open sessions, give you in-depth information
on the issues affecting your everyday practice.
This year’s mini institutes focus on the topics that interest you:
•Symptom Management |
•Private Practice |
•Sexuality and Fertility |
•Breast Cancer |
•Clinical Trials |
•Chemotherapy and Biotherapy |
•Pancytopenia |
•Lung Metastases |
•Ostomy Care |
•Skin Problems |
•Bringing Evidence to Clinical Practice |
|
Open Sessions Mean More Education, More Interaction, and More Contact
Hours
Attend 90-minute open sessions on Friday and Sunday to get even more
education—and more contact hours! This year’s open sessions
focus on a variety of hot oncology topics:
•New Drug Update |
•Patient Teaching |
•Evidence-Based Practice |
•Secondary Cancers |
•Acute Leukemia |
•Overcoming Genetics Illiteracy |
•Pain Management |
•End-of-Life Care |
•Health Policy Advocacy |
•Multisite Research |
•Symptom Management |
•Targeted/Biologic Therapy |
•Safe Handling |
•Hereditary Gynecologic Cancers |
•Active Immunotherapy for Hematologic Malignancies and Solid Tumors |
|